Suspend trials, BMCRI warns Ayurvedic doctor after claims | Bengaluru News – Times of India


BENGALURU: The ethics committee of the Bangalore Medical College and Research Institute warned Ayurvedic practitioner Dr Giridhara Kaje to suspend trials for public statements that his medicine could cure Covid-19 patients even though clinical trials are still under way.
The notice issued to Dr Kaje, principal investigator, Prashanthi Ayurvedic Centre, Rajajinagar said, that though clinical trials are in the preliminary stage and no results have been placed before the committee, he has claimed success in public. “This is unacceptable and amounts to overstepping of one’s responsibility. You are aware that any disclosure of such sensitive information will have to be with all clearances from various appropriate authorities. The above act is viewed seriously since the information is very sensitive in the present circumstance,” the notice read.
The clinical trial ‘to evaluate the efficacy and safety of tablet Bhoumya and tablet Saathmya as an add-on therapy to standard of care in Covid-19 positive patient’ is still under way.
The committe’s move comes after Kaje made several public statements that his medicine can be used to treat Covid-19 patients. Tourism minister CT Ravi, who tested positive, claimed he was cured after taking medicine prescribed by Kaje.
Kaje told STOI: “I have not received any notice from the committee. I saw it on social media and it is dated July 17. I’ve never made such statements and until the medicine is authorised, I won’t prescribe it to patients. I came across social media posts where many claimed the medicine costs Rs 150 and can cure Covid-19. I’ve already said on my Facebook page that people shouldn’t get misguided by such fake news.”
An official said, “The report he submitted is just a claim. It must go through scientific process and testing. He has shared data of his study in the public domain which is incorrect on his part. He cannot make claims without the clinical trials being completed.”
Kaje got approval from Indian Council for Medical Research to conduct clinical trials. In his proposal, he claimed that he had conducted tests on 10 patients aged between 23 and 65 year between June 7 and 25. He claimed the patients had recovered quickly by taking Bhoumya and Saathmya.
Advertisement



Source link

Advertisement

Sagar Biswas

Leave a Reply

Close Bitnami banner
Bitnami